Search Results - "Proske, V."

Efficacy and safety of sofosbuvir/ledipasvir for the treatment of patients with hepatitis C virus re-infection after liver transplantation by Ciesek, S., Proske, V., Otto, B., Pischke, S., Costa, R., Lüthgehetmann, M., Polywka, S., Klempnauer, J., Nashan, B., Manns, M.P., von Hahn, T., Lohse, A.W., Wedemeyer, H., Mix, H., Sterneck, M.

“…Background Hepatitis C virus (HCV) infection is associated with a particularly poor outcome after liver transplantation. In December 2014,…”
Get full text

Outcome and natural course of renal dysfunction in liver transplant recipients with severely impaired kidney function prior to transplantation by Horvatits, T, Pischke, S, Proske, VM, Fischer, L, Scheidat, S, Thaiss, F, Fuhrmann, V, Lohse, AW, Nashan, B, Sterneck, M

“…Background Since introduction of the MELD score in the liver allograft allocation system, renal insufficiency has emerged as an increasing problem. Here we…”
Get full text

Course of hepatitis C virus (HCV) RNA and HCV core antigen testing are predictors for reaching sustained virologic response in liver transplant recipients undergoing sofosbuvir treatment in a real-life setting by Pischke, S., Polywka, S., Proske, V.M., Lang, M., Jordan, S., Nashan, B., Lohse, A.W., Sterneck, M.

“…Background Hepatitis C virus (HCV) infection is associated with reduced graft survival in orthotopic liver transplant recipients. Treatment with the new…”
Get full text